Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
Journal of Veterinary Research
Volume 62 (2018): Numero 1 (March 2018)
Accesso libero
Xylazine regulates the release of glycine and aspartic acid in rat brain
Yi-Ming Zhang
Yi-Ming Zhang
,
Dong-Xu Yu
Dong-Xu Yu
,
Bai-Shuang Yin
Bai-Shuang Yin
,
Xin-Ran Li
Xin-Ran Li
,
Li-Na Li
Li-Na Li
,
Ya-Nan Li
Ya-Nan Li
,
Yu-Xin Wang
Yu-Xin Wang
,
Yu Chen
Yu Chen
,
Wen-Han Liu
Wen-Han Liu
e
Li Gao
Li Gao
| 30 mar 2018
Journal of Veterinary Research
Volume 62 (2018): Numero 1 (March 2018)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Articolo
Immagini e tabelle
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Pubblicato online:
30 mar 2018
Pagine:
121 - 128
Ricevuto:
15 set 2017
Accettato:
14 feb 2018
DOI:
https://doi.org/10.2478/jvetres-2018-0017
Parole chiave
rats
,
brain
,
xylazine
,
glycine
,
aspartic acid
© 2018 Y.-M. Zhang et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Fig. 1
The effect of low-dose xylazine anaesthesia on Gly neurotransmitters in rat brain. C – control group, I – induction period, A – anaesthesia period, R1 – recovery period (group R1), R2 – recovery period (group R2), R3 – recovery period ( group R3). ∗P < 0.05; ∗∗P < 0.01
Fig. 2
The effect of low-dose xylazine anaesthesia on Asp neurotransmitters in rat brain. C – control group, I – induction period, A – anaesthesia period, R1 – recovery period (group R1), R2 – recovery period (group R2), R3 – recovery period (group R3). ∗P < 0.05; ∗∗P < 0.01
Fig. 3
The effect of high-dose xylazine anaesthesia on Gly neurotransmitters in rat brain. C – control group, I – induction period, A – anaesthesia period, R1 – recovery period (group R1), R2 – recovery period (group R2), R3 – recovery period (group R3). ∗P < 0.05; ∗∗P < 0.01
Fig. 4
The effect of high-dose xylazine anaesthesia on Asp neurotransmitters in rat brain. C – control group, I – induction period, A – anaesthesia period, R1 – recovery period (group R1), R2 – recovery period ( group R2), R3 – recovery period (group R3). ∗P < 0.05; ∗∗P < 0.01
Fig. 5
Effects of different concentrations of xylazine on neurons secreting the neurotransmitter Gly. At 5, 10, 15, 20, 25, 30, 45, 60, 90, and 120 min xylazine was allowed to act on the neurons. (A) 15 μg/mL xylazine, (B) 25 μg/mL xylazine, (C) 35 μg/mL xylazine, (D) 45 μg/mL xylazine. ∗P < 0.05; ∗∗P < 0.01 versus control, #P < 0.05; ##P < 0.01 versus the minimum value
Fig. 6
Effects of different concentrations of xylazine on neurons secreting the neurotransmitter Asp. At 5, 10, 15, 20, 25, 30, 45, 60, 90, and 120 min xylazine was allowed to act on the neurons. (A) 15 μg/mL xylazine, (B) 25 μg/mL xylazine, (C) 35 μg/mL xylazine, (D) 45 μg/mL xylazine. ∗P < 0.05; ∗∗P < 0.01 versus control, #P < 0.05; ##P < 0.01 versus the minimum value